A new study published in the Journal of the American Medical Association suggests that antidepressants are the most effective way to treat depression in some people.
The study, led by the University of California, San Francisco, examined a large sample of depressed people who were treated with various antidepressants.
It found that people who took an antidepressant had significantly lower rates of depression than people who didn’t.
The study was conducted by researchers at the University at Buffalo, The Ohio State University, and the Johns Hopkins University.
It looked at patients who had been diagnosed with major depressive disorder and used a new measure of depression called the Montgomery-Asberg Depression Rating Scale (MADRS).
The MADRS is based on a five-point scale ranging from 0 to 100, with 0 representing the lowest level of depression and 100 representing the highest.
The researchers looked at data from more than 6,000 patients, and found that patients who took antidepressants had significantly reduced rates of depressive symptoms.
The researchers then took the MADRS and compared the two groups.
They found that antidepressants were more effective than placebo in treating depression.
The MADRS scales have been used for decades to assess depression, but previous studies have found that depression rates in the study population were lower than expected.
The results show that antidepressants significantly reduced the rate of depression, which suggests that they may have more long-term efficacy than previously thought.
This study may have some limitations, though.
The MADrs was only administered in people who met diagnostic criteria for depression, and it is not a diagnostic test.
Therefore, it may not accurately measure depression in the population at large.
Also, it was conducted in a single institution, so it is possible that the depression reduction might not have been a result of the drugs being prescribed to patients.
However, the study suggests that patients taking antidepressants may have an easier time getting better when they take them in combination with other medications.
The drugs used in the trial were selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptakes inhibitors (SNRI), and tricyclic antidepressants.